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Abstract
Objective Prenatal opioid exposure has been linked with impaired cognitive development, with
boys potentially at elevated risk. In the present study, we examined cognitive and language devel-
opment of children prenatally exposed to opioids, with an additional focus on sex differences.
Methods A sample of 378 children (n¼194 girls and n¼ 184 boys) aged 1.2–42.8 months was
drawn from the Danish Family Outpatient Clinic database. Developmental outcomes were assessed
using the Bayley-III cognitive and language scales, and substance exposure was determined with
urine screening and/or verbal report. Children exposed to opioids (n¼ 94) were compared to chil-
dren with no prenatal substance exposure (n¼ 38), and children exposed to alcohol (n¼ 131) or to-
bacco (n¼ 115). Group and sex differences were investigated with separate linear mixed models
for each Bayley scale, controlling for concurrent cannabis exposure. Results There were signifi-
cantly reduced scores in opioid-exposed boys compared to boys with no prenatal substance expo-
sure, but no difference between opioid-exposed and nonexposed girls. Additionally, alcohol-
exposed boys had lower cognitive scores than nonexposed boys, and alcohol-exposed girls had
lower scores on both scales compared to opioid-exposed girls. There were otherwise no significant
differences according to group, sex, or scale. Conclusions The present findings indicate poorer
cognitive and language development in boys after prenatal opioid exposure. As academic perfor-
mance is rooted in cognitive functioning, long-term follow-up might be necessary for exposed
children.
Key words: cognitive development; language development; prenatal opioid exposure; sex differences.
Introduction
Opioid maintenance treatment (OMT) has played a
large part in improving outcomes for opioid-
dependent patients, and current guidelines recommend
maintenance treatment with methadone or buprenor-
phine for pregnant opioid-dependent women (World
Health Organization, 2014). Yet, there is increasing
evidence of poorer health and development in children
prenatally exposed to opioids. Opioids cross the pla-
centa and the blood–brain barrier of the developing
fetus (Rosen & Pippenger, 1975; Syme, Paxton, &
Keelan, 2004). In the neonate, prenatal methadone or
buprenorphine exposure is associated with lower birth
weight (e.g., Nørgaard, Nielsson, & Heide-Jørgensen,
2015; Patrick et al., 2015), lower average gestational
age at birth (e.g., Nørgaard et al., 2015; Sarfi,
Martinsen, Bakstad, Røislien, & Waal, 2009), and
smaller head circumference (e.g., Chasnoff, Hatcher,
& Burns, 1980; Lifschitz, Wilson, Smith, & Desmond,
1985) compared to nonexposed groups. Neonatal
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abstinence syndrome (NAS) occurs in around 50% of
exposed infants (Reddy, Davis, Ren, & Greene,
2017), although the reported prevalence varies be-
tween studies.
Children exposed to illicit opioids and polysubstan-
ces in utero also demonstrate lower levels of general
cognitive (Baar & Graaff, 1994; Nygaard, Moe,
Slinning, & Walhovd, 2015) and fine-motor function-
ing (Bunikowski et al., 1998; Nygaard, Slinning, Moe,
& Walhovd, 2017) throughout childhood and adoles-
cence, as well as regulatory problems (Nygaard,
Slinning, Moe, & Walhovd, 2016; Ornoy, Segal, Bar-
Hamburger, & Greenbaum, 2001). Existing evidence
suggests that toddlers prenatally exposed to metha-
done or buprenorphine are at risk for some of the
same neurodevelopmental impairments, including
poorer gross and fine-motor functioning (Hans &
Jeremy, 2001; Strauss, Starr, Ostrea, Chavez, &
Stryker, 1976), language abilities (Baar & Graaff,
1994; Beckwith & Burke, 2015; Salo et al., 2009),
and cognitive functioning (Baar & Graaff, 1994;
Bauman & Levine, 1986; Beckwith & Burke, 2015;
Hans & Jeremy, 2001; Salo et al., 2010). In spite of
these differences, opioid-exposed children usually
score within the range of age-appropriate norms
(Nygaard et al., 2017; Strauss et al., 1976). Moreover,
in utero exposure to opioids is associated with less se-
vere outcomes compared to in utero exposure to alco-
hol, which has been consistently linked with impaired
cognitive functioning (Behnke, Smith, Committee on
Substance Abuse, & Committee on Fetus and
Newborn, 2013; Mattson & Riley, 1998). Prenatal to-
bacco exposure may also have detrimental effects on
development, though to a lesser extent than alcohol
(Behnke et al., 2013), thus the high prevalence of ciga-
rette smoking reported for women in OMT (e.g.,
Mactier, Shipton, Dryden, & Tappin, 2014) may con-
found outcomes associated with in utero opioid
exposure.
Prenatal opioid exposure may affect boys and girls
differently (Alaedini, Haddadi, & Asadian, 2017).
One early study of children exposed to methadone in
utero showed that boys scored significantly lower
than girls on the Bayley-II mental development index,
which assesses early cognitive and language develop-
ment jointly, at 1 and 2 years of age (Suffet &
Brotman, 1984). In a more recent article (Nygaard
et al., 2015), differences in cognitive abilities between
opioid-exposed and nonexposed children (lower in ex-
posed children) were substantially larger for boys than
for girls the first few years of life, but group differen-
ces increased over time for girls, while they remained
relatively stable for boys. Boys also appear to be more
adversely impacted than girls after prenatal exposure
to cocaine (Kestler, Bennett, Carmody, & Lewis,
2012). Thus, boys could be at greater risk after in
utero opioid exposure during the first few years of life,
although further evidence is needed to evaluate this
claim.
Prescription opioid abuse among pregnant women
is on the rise (Krans & Dunn, 2014; Reddy et al.,
2017), with rates as high as 29% in some populations
(Epstein et al., 2013). This is particularly the case for
pain-management opioids, though these are seldom in-
cluded in studies of the effects of prenatal exposure.
Therefore, the aim of the present study was to com-
pare the performance of children exposed to opioid
analgesics and/or maintenance medication in utero to
that of comparison groups with other or no in utero
substance exposure on the Bayley-III cognitive and
language scales. Children with additional exposure to
heroin were also included, but constituted a very small
minority of the sample. We hypothesized that opioid-
exposed children would perform worse than children
with no prenatal substance exposure, as well as to-
bacco-exposed children, but better than alcohol-ex-
posed children. Group differences between opioid-
exposed and nonexposed children were expected to be
larger for boys than girls. The current study adds to
the literature on cognitive outcomes after prenatal opi-
oid exposure by including opioid analgesics, in addi-
tion to maintenance medication and heroin.
Moreover, our sample size exceeds that of most previ-
ous studies, increasing our power to detect small
group differences. Our results will thus aid our under-
standing of sex differences in cognitive and language
development after prenatal opioid exposure.
Methods
Setting
This is a historical cohort study where we analyzed
data collected by the regional Danish Family
Outpatient Clinics (FOCs) over the course of 7 years.
The FOCs provide medical care and guidance primar-
ily for pregnant women, who either have or have had
(within 2 years of pregnancy) a substance abuse prob-
lem, and their children (Sundhetsstyrelsen, 2015).
Care is provided through an interdisciplinary ap-
proach by a team consisting of medical specialists
(e.g., pediatricians and obstetricians), midwives, psy-
chologists, social workers, and secretaries, on an out-
patient basis. Such care may include regular checkups
during pregnancy, detoxification or maintenance
treatment, treatment and care of the neonate, and
family support during pregnancy and after birth. The
child may attend regular examinations by a doctor
and a psychologist until it reaches school age.
Children without prenatal substance exposure, but
where the mother has or has had problems related to
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substance use, are also eligible for follow-up if deemed
necessary by the FOCs. As the FOCs’ aim is to be the
main health care providers for pregnant women with
substance abuse problems in Denmark, the database is
likely to include the majority of this population, thus
constituting a highly representative sample. Data col-
lection for the database was approved by the Danish
Data Protection Agency. The usual requirement of in-
formed consent was waived by both the Danish Data
Protection Agency and the Norwegian Regional
Committees for Medical and Health Research Ethics.
For in-depth information on the work of the FOCs,
please see Sundhetsstyrelsen (2015).
Participants
The present sample of 378 mother–child dyads (in-
cluding 1 twin pair) was drawn from the FOC data-
base, which at the time of analysis contained
information about the families who had been assisted
by the regional FOCs between 2010 and 2016.
Participants were selected based on the following in-
clusion criteria: (a) A recorded child sex, (b) child as-
sessment on the Bayley-III cognitive and/or language
subscales, (c) information indicating either absence of
prenatal substance exposure or exposure to tobacco,
alcohol, and/or opioids, and (d) no registered medical
diagnoses that could affect cognitive outcomes (see
Figure 1). Moreover, children diagnosed with NAS
were excluded from all but the opioid exposure group,
and children diagnosed with fetal alcohol syndrome
(FAS) were excluded from all but the alcohol exposure
group. While NAS can occur in response to a variety
of substances, it is most commonly and consistently
reported after prenatal opioid exposure. Children
were divided into four groups according to exposure:
(a) prenatal exposure to opioids (no further exclusion
criteria), (b) prenatal exposure to alcohol (and not
opioids), (c) prenatal exposure to tobacco (and not al-
cohol or opioids), and (d) no prenatal substance expo-
sure, but mothers who had been in contact with the
FOCs about substance use problems within 2 years of
the pregnancy.
Substance exposure was determined by verbal re-
port and/or urine screening (Table I). As most expo-
sure was determined by the former, it is likely that
substance use was underreported. Neonatal abstinence
syndrome was diagnosed according to Finnegan’s
Neonatal Abstinence Scoring System (Finnegan,
Connaughton, Kron, & Emich, 1975) and treated
with morphine (n¼13) and phenobarbital (n¼3). For
nine children in the opioid group, the specific type of
opioid could not be identified, but these were not ex-
cluded from analyses. Fetal alcohol syndrome (FAS)
was diagnosed by specialist pediatricians, and five
children in the alcohol-exposed group were diagnosed
with FAS. Median age at testing was 10.4 months
(range 1.2–42.8 months) for the cognitive scale and
9.4 months (range 1.2–35.7 months) for the language
scale.
Outcome
The cognitive and language scales of the Bayley Scales
of Infant and Toddler Development (Bayley-III; Albers
& Grieve, 2007) were used to assess child cognitive
and language development, respectively. The Bayley-
III consists of a standard variety of measurements
intended to evaluate development in infants and tod-
dlers and is one of the most widely used tools for this
purpose. Both the cognitive and language scales are
demonstrated to have good reliability and validity
across age groups (Albers & Grieve, 2007). In terms
of predictive validity, Bode, D’Eugenio, Mettelman,
and Gross (2014) found that Bayley-III cognitive and
language scores at 2 years of age were predictive of
Weschler Preschool and Primary Scale of Intelligence-
III scores at 4 years of age, with correlations of .81
and .78, respectively. However, other studies find lim-
ited predictive validity of the Bayley-III (Månsson,
Stjernqvist, Serenius, ødén, & Källén, 2019; Spencer-
Smith, Spittle, Lee, Doyle, & Anderson, 2015).
In the present analysis, we present age-corrected
standardized scores (mean ¼ 100, SD ¼ 15), which
have a possible range between 55 and 145 for the cog-
nitive scale and 47 and 153 for the language scale.
Most of the children (n¼218) were tested at least
twice, up to a maximum of 7 times (n¼ 1), yielding a
total of n¼ 747 test administrations on the cognitive
scale and n¼633 test administrations on the language
scale.
Analyses
Effects of in utero substance exposure were examined
separately for Bayley-III cognitive and language scores
in linear mixed models, with factors Exposure Group,
Sex, Group  Sex, and Prenatal Cannabis Exposure,
and covariates Age and Maternal Education as fixed
effects regressors. Prenatal cannabis exposure was
added as a control variable due to the potential associa-
tion between in utero cannabis exposure and adverse
neonatal and cognitive outcomes (Calvigioni, Hurd,
Harkany, & Keimpema, 2014; Huizink, 2014). The
mixed model allows for controlling for variable recur-
rences of repeated measures. As 175 children lacked
data on maternal education, and as age was lacking for
eight test administrations, multiple imputation was
used to provide estimates for the missing values, and
subsequent analyses were performed with pooled esti-
mates for 200 imputations. This was preferred to con-
ducting the analyses without controlling for these
additional variables, as maternal socioeconomic status
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may be an important factor for child development
(McLoyd, 1998). The main objective was to compare
the exposure groups with the nonexposed group, thus
the latter was set to 0 in the models. Analyses were also
repeated with the opioid group set to 0, in order to ex-
plore differences between this and other exposure
groups. Effects were evaluated at a ¼ .05. Imputation
and analyses were performed in IBM SPSS Statistics 25.
Assessed for eligibility  
(n = 2714) 
Excluded   
(n = 210) 
Sex recorded 
(n = 2509) 
Bayley Cognitive and/or Language 
scale assessment 
(n = 827) 
Excluded   
(n = 760 girls) 
(n = 917 boys) 
In utero substance exposure within the 
four groups of interest 
(n = 389) 
Excluded   
(n = 219 girls) 
(n = 219 boys) 
No relevant birth diagnoses 
(n = 388)
Excluded   
(n = 1 girl, tobacco group) 
No NAS outside opioid group or FAS 
outside alcohol group 
(n = 378) 
Excluded FAS 
(n = 2 girls, tobacco group) 
(n = 1 girl, opioid group) 
Excuded NAS 
(n = 2 girls, tobacco group) 
(n = 4 boys, tobacco group) 
(n = 1 boy, alcohol group) 
Included 
(n = 378)
Figure 1. Selection process.
Abbreviations: FAS¼fetal alcohol syndrome; NAS¼neonatal abstinence syndrome. Numbers are referring to children in
the database. The child excluded due to relevant birth diagnoses was diagnosed with sepsis.
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Results
Sample characteristics are displayed in Table II, and
group means and SDs for Bayley cognitive and lan-
guage scores by sex are displayed in Figures 2 and 3,
respectively (exact means and SDs in Supplementary
Table 1). Linear mixed models revealed that children
with recorded maternal education were, on average,
2.6 months (95% CI [1.6, 3.7]) and 1.7 months (95%
CI [.6, 2.8]) younger at cognitive and language
assessment, respectively, compared to children with-
out recorded maternal education. Otherwise, there
were no significant differences between these groups
on any measure listed in Table II. Twelve children
(four in the opioid group, five in the alcohol group,
and three in the tobacco group) scored at least two
SDs below the mean on at least one test administra-
tion, of which eight children scored below 70 on the
cognitive scale, and four children scored below 70 on
the language scale.
Results of the linear mixed models are presented in
Tables III and IV for cognitive and language scores, re-
spectively. There were no significant main effects of
Age, Maternal Education, or Sex for either scale. The
main effect of prenatal cannabis exposure was signifi-
cant for the language scale, in the direction of higher
scores with prenatal exposure (mean difference 2.46,
95% CI [0.73, 4.19]). There was evidence of a Opioid
 Sex interaction effect for both the cognitive (mean
difference 65.78 [girls/boys], 95% CI [11.64, 0.07])
and language (mean difference 66.63 [girls/boys],
95% CI [12.41, 0.86]) scales, in the direction of
lower scores for opioid-exposed boys. Boys in the opi-
oid group had lower cognitive scores compared to
boys in the nonexposed group (mean difference
5.82, 95% CI [9.92, 1.47]), with the correspond-
ing comparison for the language scale falling just
Table I. Substance Exposure per Exposure Group/Method of Confirming Positive Exposure
Prenatal opioid
exposure n (% of
group)(n¼94)
Prenatal alcohol
exposure n (% of
group)(n¼131)
Prenatal tobacco
exposure n (% of
group)(n¼ 115)
Verbal confir-
mation n (% of
substance)
Positive urine
screening n (%
of substance)
Alcohol 3 (3.2) 131 (100.0) NA 134 (100.0) NA
Tobacco 29 (30.9) 58 (44.3) 115 (100.0) 203 (100.0) NA
Opioids
Buprenorphine 5 (5.3) NA NA 5 (100.0) 1 (20.0)
Codeine 6 (6.4) NA NA 6 (100.0) 1 (16.7)
Fentanyl 2 (2.1) NA NA 2 (100.0) 0 (0.0)
Heroin 1 (1.1) NA NA 1 (100.0) 1 (100.0)
Ketobemidone 2 (2.1) NA NA 2 (100.0) 0 (0.0)
Methadone 29 (30.9) NA NA 24 (82.8) 11 (37.9)
Morphine 24 (25.5) NA NA 24 (100.0) 5 (20.8)
Oxycodone 5 (5.3) NA NA 5 (100.0) 3 (60.0)
Tramadol 27 (28.7) NA NA 27 (100.0) 2 (7.4)
Other substances
Amphetamine 3 (3.2) 14 (10.7) 5 (4.3) 19 (86.4) 3 (13.6)
Antidepressants 8 (8.5) 1 (0.8) 4 (3.5) 13 (100.0) NA
Antipsychotics 2 (2.1) 0 (0.0) 0 (0.0) 2 (100.0) NA
Benzodiazepines
(prescribed and illicit)
10 (10.6) 1 (0.8) 6 (5.2) 13 (76.5) 6 (35.3)
Cannabis 15 (16.0) 36 (27.5) 49 (42.6) 84 (84.0) 50 (50.0)
Cocaine 1 (1.1) 6 (4.6) 0 (0.0) 6 (85.7) 1 (14.3)
Ecstasy/MDMA 2 (2.1) 2 (1.5) 0 (0.0) 3 (75.0) 1 (25.0)
Psychotropic medication
(prescribed)
1 (1.1) 2 (1.5) 4 (3.5) 7 (100.0) NA
Abbreviations: MDMA¼ 3.4-methylenedioxymethamphetamine; NA–not applicable.
Note. Urine screening was performed for amphetamine, benzodiazepines, cannabis, cocaine, ecstasy, and opioids (including separate tests for
buprenorphine, methadone, and tramadol). The no-exposure group is not included, as no children in this group had any evidence of prenatal
substance exposure.
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Figure 2. Bayley-III Cognitive group means per exposure
group and sex.
Note. For n ¼ 358 administrations for boys and n ¼ 389
administrations for girls. Error bars represent þ/- one stan-
dard deviation.
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within the set level of significance (mean difference
3.98, 95% CI [7.96, 0.00]). Alcohol-exposed boys
also had lower cognitive scores as compared to nonex-
posed boys (mean difference 3.92, 95% CI [7.83,
0.01]). There was no evidence of reduced scores in
tobacco-exposed boys, and no significant differences
between any groups for girls.
The analyses were then repeated with the opioid-
exposed children serving as the comparison group.
There was a highly significant effect of Sex, girls hav-
ing overall higher scores both on the cognitive (mean
difference 6.09, 95% CI [3.00, 9.18]) and language
(mean difference 5.26, 95% CI [2.23, 8.39]) scales
compared to boys. There was also a significant Group
 Sex interaction for the alcohol group on both the
cognitive (mean difference 5.14, 95% CI [1.19, 9.09])
and language (mean difference 4.01, 95% CI [0.11,
7.91]) scales, with comparisons within each sex re-
vealing lower scores for alcohol compared to opioid-
exposed girls (mean difference 3.24, 95% CI
[6.03, 0.44] for the cognitive scale, and mean dif-
ference 2.69, 95% CI [5.42, 0.04] for the language
scale), but no differences for boys. There were no sig-
nificant differences for the tobacco group.
The general pattern remained when the analyses
were performed with the unimputed dataset, without
maternal education in the model, and the eight cases
lacking age at testing excluded (Supplementary Tables
2 and 3). However, when only those participants with
full datasets were included (i.e., using unimputed data,
and controlling for maternal education), all significant
effects disappeared (Supplementary Tables 4 and 5).
These two sets of Supplementary tables directly mirror
Tables III and IV in the main text, and estimates for
main and interaction effects are thus comparable be-
tween the two sets of analyses.
Table II. Sample Characteristics per Exposure Group
Prenatal opioid
exposure (n¼94)
Prenatal alcohol
exposure (n¼ 131)
Prenatal tobacco
exposure (n¼115)
No prenatal expo-
sure (n¼ 38)
p
Girls, n (%) 49 (52.1%) 66 (50.4%) 62 (53.9%) 17 (44.7%)
.79
Age at testing in months
(Bayley cognitive scale),
mean (SD)
12.58 (8.02) 13.32 (8.25) 11.60 (6.61) 12.84 (7.68)
.10n ¼ 176 (test
administrations)
n ¼ 264 (test
administrations)
n ¼ 235 (test
administrations)
n ¼ 67 (test
administrations)
Age at testing in months
(Bayley language scale),
mean (SD)
11.42 (6.94) 12.29 (7.75) 10.57 (5.98) 12.29 (7.35)
.07n ¼ 149 (test
administrations)
n ¼ 222 (test
administrations)
n ¼ 202 (test
administrations)
n ¼ 57 (test
administrations)
Birth weight in milligrams,
mean (SD)
3,177.93 (597.23) 3,127.41 (658.45) 3,078.43 (632.85) 3,093.05 (736.55)
.73n ¼ 94 n ¼ 131 n ¼ 113 n ¼ 37
Birth head circumference in
centimeters, mean (SD)
34.39 (1.66) 34.06 (2.00) 34.01 (2.15) 33.56 (3.03)
.32n ¼ 83 n ¼ 110 n ¼ 98 n ¼ 25
Gestational age in weeks,
mean (SD)
38.67 (2.28) 39.10 (2.55) 39.13 (2.69) 38.63 (3.40)
.46n ¼ 94 n ¼ 124 n ¼ 113 n ¼ 38
SGA, n (%) 7 (7.4%) 13 (10.5%) 11 (10.0%) 4 (10.5%)
.88n ¼ 94 n ¼ 124 n ¼ 110 n ¼ 38
NAS, n (%) 13 (31.7%) NA NA NA
NAn ¼ 41
Not discharged to biological
parent(s), n (%)
7 (12.7%) 13 (17.8%) 9 (12.0%) 3 (17.6%)
.73n ¼ 55 n ¼ 73 n ¼ 75 n ¼ 17
Maternal education, median
(IQR)
2 (2) 2 (1) 2 (1) 2 (0)
.08n ¼ 48 n ¼ 71 n ¼ 76 n ¼ 8
Abbreviations: NA ¼ not applicable; NAS ¼ neonatal abstinence syndrome; SGA ¼ small for gestational age.
Note. Age at testing was calculated across all test administrations. Maternal education was divided into six levels (1 ¼ less than middle school
education, 2 ¼ middle school education or equivalent, 3 ¼ high school education and/or non-university education, 4 ¼ university education <
3 years, 5 ¼ university education 3-4 years, 6 ¼ university education > 4 years). SGA was defined as having a birth weight in the 22nd percen-
tile or lower. Statistical significance of group differences were calculated with analyses of variance (birth weight, head circumference, gesta-
tional age, and maternal education), chi-square tests (sex, SGA, and not discharged to biological parents), and linear mixed models (age at
testing).
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Figure 3. Bayley-III Language group means per exposure
group and sex.
Note. For n ¼ 305 administrations for boys, and n ¼ 328
administrations for girls. Error bars represent þ/- one stan-
dard deviation.
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Discussion
The present results reveal reduced cognitive and lan-
guage development only in boys after in utero expo-
sure to opioids. Opioid-exposed boys lagged behind
an average of 5.82 points on the Bayley cognitive scale
and 3.98 points on the language scale, as compared to
nonexposed boys. This represents a difference of
roughly a third of the expected standard deviation of
15 for standardized scores on the Bayley scales, thus
scores remain within the normal range. There was a
significant Group  Sex interaction effect, and group
differences between opioid-exposed and nonexposed
girls did not reach statistical significance for either
scale. Thus, the association of lower cognitive and lan-
guage scores with in utero opioid exposure appears to
be sex specific, with adverse outcomes in boys, and
girls not much different from nonexposed groups.
These results are of particular importance given the
paucity of studies investigating sex differences after in
utero opioid exposure. Indeed, to the authors’ knowl-
edge, this is the first study to investigate sex
differences after in utero exposure to analgesic
opioids, in addition to maintenance medication. The
current study thus elaborates on the existing literature
on sex differences after in utero opioid exposure,
while replicating previous findings on OMT medica-
tion and illicit opioids with opioid analgesics.
The present findings are congruent with previous
studies investigating the interaction between prenatal
opioid exposure and sex on cognitive development. In
a study by Suffet and Brotman (1984), opioid-exposed
girls had higher cognitive scores than opioid-exposed
boys at 1–2 years of age. Both Nygaard et al. (2015)
and Moe and Slinning (2001) found elevated group
differences on developmental tests for boys after in
utero opioid and polysubstance exposure at 1–3 years
of age, with girls not much different from children
with no known risk. The same pattern was suggested
in a recent review by Alaedini et al. (2017). It is
unclear why boys appear to be more adversely affected
by in utero opioid exposure than girls in some
domains. Boys may be more vulnerable to intrauterine
Table IV. Group Differences in Bayley-III Language Scores by Sex
Boys Girls
Estimate 95% CI [upper, lower] p Estimate 95% CI [upper, lower] p
Prenatal opioid exposure group 3.98 [7.96, 0.00] .05 2.65 [1.66, 6.96] .23
Prenatal alcohol exposure group 2.66 [6.44, 1.12] .17 0.04 [4.24, 4.17] .99
Prenatal tobacco exposure group 2.20 [6.14, 1.73] .27 1.95 [2.27, 6.18] .37
Prenatal cannabis exposure 2.46 [0.73, 4.19] .005 2.46 [0.73, 4.19] .005
Age 0.09 [0.19, 0.02] .11 0.09 [0.19, 0.02] .11
Maternal education 0.10 [0.80, 1.01] .82 0.10 [0.80, 1.01] .82
Sex 1.37 [3.55, 6.29] .59 1.37 [6.29, 3.55] .59
Opioids  Sex 6.63 [12.41, 0.86] .02 6.63 [0.86, 12.41] .02
Alcohol  Sex 2.62 [8.13, 2.88] .35 2.62 [2.88, 8.13] .35
Tobacco  Sex 4.16 [9.73, 1.41] .14 4.16 [1.41, 9.73] .14
Note. Linear mixed models analysis with pooled group estimates for n ¼ 633 test administrations (n ¼ 319 children) based on 200 imputed
datasets. The non-exposed group is set to zero in the analyses. Sex was set to zero for boys and girls, respectively, in two separate analyses,
yielding group comparisons for each sex. Estimates are presented as Bayley-III standardized scores.
Table III. Group Differences in Bayley-III Cognitive Scores by Sex
Boys Girls
Estimate 95% CI [upper, lower] p Estimate 95% CI [upper, lower] p
Prenatal opioid exposure group 5.82 [9.92, 1.72] .005 0.03 [4.48, 4.41] .99
Prenatal alcohol exposure group 3.92 [7.83, 0.01] .05 3.27 [7.57, 1.03] .14
Prenatal tobacco exposure group 3.22 [7.25, 0.81] .12 0.76 [5.12, 3.60] .73
Prenatal cannabis exposure 1.38 [0.36, 3.13] .12 1.38 [0.36, 3.13] .12
Age 0.04 [0.05, 0.14] .38 0.04 [0.05, 0.14] .38
Maternal education 0.52 [0.47, 1.52] .30 0.48 [.047, 1.52] .30
Sex 0.31 [5.30, 4.69] .90 0.31 [4.69, 5.30] .90
Opioids  Sex 5.78 [11.64, 0.07] .05 5.78 [0.07, 11.64] .05
Alcohol  Sex .065 [6.21, 4.92] .82 0.65 [4.92, 6.22] .82
Tobacco  Sex 2.46 [8.11, 3.20] .40 2.46 [3.20, 8.11] .40
Note. Linear mixed models analysis with pooled group estimates for n = 747 test administrations (n = 375 children) based on 200 imputed
datasets. The non-exposed group is set to zero in the analyses. Sex was set to zero for boys and girls, respectively, in two separate analyses,
yielding group comparisons for each sex. Estimates are presented as Bayley-III standardized scores.
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factors typically occurring with substance use (Kestler
et al., 2012). Additionally, boys may be less adept at
emotional self-regulation than girls, thus necessitating
greater external help to downregulate (Weinberg,
Tronick, Cohn, & Olson, 1999). It could be that
mothers with substance abuse problems are less capa-
ble of assisting their children in this type of regulation
(Salo et al., 2010), resulting in cumulative regulatory
risk factors for boys. Children exposed to drugs in
utero may in general have impaired behavioral regula-
tion (Lester & Tronick, 1994), and Moe and Slinning
(2001) propose that resulting difficulties in achieving
a calm alert state is a suboptimal base for learning,
thus placing prenatally exposed boys at particular
risk.
It should be noted that performance among girls
with prenatal opioid exposure has been shown to dete-
riorate as they reach kindergarten or school age
(Nygaard et al., 2015), suggesting that even though
there were no significant differences for girls in the
present sample, these may emerge with age.
Additionally, lower cognitive performance among opi-
oid-exposed children as compared to nonexposed chil-
dren may in general persist as they reach school
(Nygaard et al., 2015) and even young adult age
(Nygaard et al., 2017). A recent population-based
study by Oei et al. (2017) revealed a progressive deficit
in academic performance among children diagnosed
with NAS at birth, where by grade 7 children with
NAS scored lower than a comparison group in grade
5. Increased risk of poorer academic achievement may
necessitate close long-term follow-up of opioid-ex-
posed children.
We were also interested in exploring whether there
were group and/or sex differences for the alcohol- and
tobacco-exposed groups. There were no significant
differences between tobacco-exposed and opioid-ex-
posed boys or girls. Our data thus suggest similar out-
comes in children with prenatal exposure to tobacco
and opioids. However, there was a significant differ-
ence between opioid-exposed and nonexposed boys,
but not between tobacco-exposed and nonexposed
boys, in addition to a larger difference in scores in the
former. These results indicate a stronger association
between prenatal exposure and cognitive development
for opioids as compared to tobacco. It should be noted
that the relatively high level of tobacco exposure in
the opioid and alcohol groups in the present sample
limits conclusions regarding the effects of these sub-
stances. Future studies are needed to determine the rel-
ative effects of prenatal tobacco and opioids on early
cognitive development. Contrary to other studies (e.g.,
Cornelius & Day, 2009), the tobacco-exposed group
did not perform significantly different compared to
the nonexposed group. The association between in
utero tobacco exposure and adverse cognitive
outcomes is inconsistent, and the lack of differences in
the present study could have been due to the limited
number of participants relative to previous studies of
prenatal tobacco exposure (England et al., 2017), or
the presence of other risk factors drowning out the ef-
fect of tobacco.
Consistent with our hypotheses, the alcohol-ex-
posed girls scored lower on both the cognitive and lan-
guage scale compared to the opioid-exposed girls.
There were, however, no significant differences be-
tween alcohol-exposed girls and girls with no prenatal
substance exposure. Alcohol-exposed boys scored
lower than nonexposed boys on the cognitive scale,
with no significant differences between alcohol-ex-
posed and opioid-exposed boys for either scale. The
overall pattern of results thus seems to suggest that
boys exposed to either opioids or alcohol in utero ex-
perience a similar negative impact on cognitive ability,
while for girls this is only the case for alcohol expo-
sure. However, this account is speculative, as there
were no significant differences between alcohol and
nonexposed girls. This was somewhat surprising,
given the well-established link between prenatal alco-
hol exposure and intellectual impairment (Behnke
et al., 2013; Mattson & Riley, 1998). A possible ex-
planation for this could be that the overall extent of al-
cohol exposure may have been relatively low in this
group, as group inclusion criterion was any exposure
to alcohol during gestation. Finally, we found a posi-
tive effect of prenatal cannabis exposure on Bayley
language scores. This effect was unexpected, though
longitudinal human studies have not consistently
revealed adverse outcomes in children with prenatal
exposure to cannabis (Huizink, 2014).
It should be noted that all significant differences be-
tween nonexposed and substance-exposed children
disappeared when the analyses were performed includ-
ing only those children who had full datasets. These
models were performed with unimputed data, and
thus had lower sample sizes of n¼ 203 and n¼ 201
children for the cognitive and language scale, respec-
tively. Indeed, only eight children in the nonexposed
group were included in this set of analyses, and the
results should therefore be interpreted with caution.
The results of these analyses are displayed in
Supplementary Tables 4 and 5 and can be compared
with results of the main analyses in Tables III and IV.
As is evident, estimated differences between exposure
groups change when the analyses are performed with
the smaller sample, thus the lack of significant effects
is unlikely to be due just to a reduction in power.
Instead, these results might indicate that children
without recorded maternal education had systemati-
cally different Bayley scores compared to children
with recorded maternal education. Children with
recorded maternal education were assessed on average
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1–2 months earlier than children without recorded
maternal education, otherwise there were no signifi-
cant differences between these groups on any measure.
Age at assessment was included as a covariate in all
models and was not significantly associated with
scores in the models including the full sample.
Therefore, it might be that children with and without
recorded maternal education differed on unmeasured
confounding factors, which could account for the dif-
ferences in the results. It is also unclear why maternal
education was unrelated to cognitive and language
outcomes in the current sample, as the link between
maternal socioeconomic variables and development is
well established (Bradley & Corwyn, 2002). This
could be due to the somewhat low variability of edu-
cation levels around a low median, corresponding to
less than a high school education.
An important strength of the present study is the
relative homogeneity between comparison groups, as
all children in the sample were under the care of a
FOC. As the FOCs are mainly intended for women
with a current or previous substance abuse problem,
all children in the present sample were likely born to
mothers with such issues, regardless of their exposure
status. Moreover, the four exposure groups did not
differ significantly on perinatal variables (birth
weight, gestational age, etc.) or likelihood of being dis-
charged to foster or institutional care. However, the
children included in this study constitute a vulnerable
sample with a number of risk factors, any of which
may overshadow the possible direct or indirect effects
of in utero substance exposure. Multiple studies find
that reduced cognitive and/or motor functioning in
drug-exposed children is related to social environment
factors (Hans & Jeremy, 2001; Lifschitz et al., 1985;
Messinger et al., 2004), which might also modulate
the effect of substance exposure (Marcus, Hans, &
Jeremy, 1984). Moreover, women in maintenance
treatment are often of lower socioeconomic status
than no-risk groups (Sarfi et al., 2009) and may em-
ploy less optimal parenting strategies in interaction
with their children (Bauman & Levine, 1986; Salo
et al., 2010). Such confounding is inherently difficult
to disentangle and adjust for, hence residual con-
founding is always a potential problem in clinical
studies on substance abuse.
One important limitation in the present study is po-
tential confounding by polysubstance exposure. The
relatively high rate of tobacco exposure in the opioid
and alcohol groups in particular may have confounded
outcomes for these groups. However, we believe that
a comparison group of tobacco-exposed children, ex-
cluding alcohol or opioid exposure, partly addresses
this concern, as effects attributable to tobacco use
alone should emerge in the comparison between this
and the nonexposed group. Exposure to any one
substance was <11% for all other substances in all
groups, thus we do not believe this had a major impact
on the outcomes. The relatively low number of chil-
dren in the nonexposed group is another limitation of
the present study, as this may have limited our power
to detect group differences. Moreover, the use of med-
ical records, and thus lack of control over data collec-
tion, made it difficult to quantify and control for
timing, duration, and extent of prenatal exposure,
leaving room for information bias (Kesmodel, 2018).
This may have contributed to depressed group differ-
ences, insofar as negligible levels of substance expo-
sure (e.g., one cigarette and one alcoholic drink) were
combined with and potentially diluted the effects of
heavy levels of exposure. This is one potential expla-
nation for why we were not able to clearly replicate
previous findings of impaired cognitive functioning in
tobacco- and alcohol-exposed children. Similarly,
grouping together children exposed to “heavy”
opioids (e.g., heroin) and “light” opioids (e.g., co-
deine) may conceal potential variability attributable to
exposure to different kinds of opioids, although only
one child in the present sample was exposed to heroin
in utero. Further lack of precision in substance expo-
sure estimates may also have been introduced from us-
ing maternal self-report as the main indicator of
exposure, as this could mean that use was underre-
ported. Finally, the relatively low median age at as-
sessment of 9.4 months for the Bayley language scale
could have reduced the sensitivity of this measure, as
problems with language development may be difficult
to detect this early in life.
Conclusions
The above limitations notwithstanding, the present
results support the possibility that prescribed opioids
could be related to delayed early cognitive and lan-
guage development in boys. These findings are partic-
ularly alarming given the increasing user rates among
pregnant women and should assist in informing treat-
ment guidelines for pregnant women in opioid mainte-
nance therapy. Moreover, our results, in connection
with previous studies, underline the importance of fu-
ture research investigating developmental differences
after in utero substance exposure for each sex sepa-
rately. Reduced cognitive functioning may later be as-
sociated with deteriorating academic performance in
opioid-exposed children, and the children and their
families might therefore need additional long-term fol-
low-up.
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